Turn down for what? Patient outcomes associated with declining increased infectious risk kidneys

Mary G. Bowring, Courtenay M. Holscher, Sheng Zhou, Allan B Massie, Jacqueline Garonzik, Lauren M. Kucirka, Sommer Elizabeth Gentry, Dorry Segev

Research output: Contribution to journalArticle

Abstract

Transplant candidates who accept a kidney labeled increased risk for disease transmission (IRD) accept a low risk of window period infection, yet those who decline must wait for another offer that might harbor other risks or never even come. To characterize survival benefit of accepting IRD kidneys, we used 2010-2014 Scientific Registry of Transplant Recipients data to identify 104 998 adult transplant candidates who were offered IRD kidneys that were eventually accepted by someone; the median (interquartile range) Kidney Donor Profile Index (KDPI) of these kidneys was 30 (16-49). We followed patients from the offer decision until death or end-of-study. After 5 years, only 31.0% of candidates who declined IRDs later received non-IRD deceased donor kidney transplants; the median KDPI of these non-IRD kidneys was 52, compared to 21 of the IRDs they had declined. After a brief risk period in the first 30 days following IRD acceptance (adjusted hazard ratio [aHR] accept vs decline: 1.222.063.49, P = .008) (absolute mortality 0.8% vs. 0.4%), those who accepted IRDs were at 33% lower risk of death 1-6 months postdecision (aHR 0.500.670.90, P = .006), and at 48% lower risk of death beyond 6 months postdecision (aHR 0.460.520.58, P < .001). Accepting an IRD kidney was associated with substantial long-term survival benefit; providers should consider this benefit when counseling patients on IRD offer acceptance.

Original languageEnglish (US)
JournalAmerican Journal of Transplantation
DOIs
StateAccepted/In press - Jan 1 2017

Fingerprint

Kidney
Kidney Diseases
Tissue Donors
Transplants
Survival
Registries
Counseling
Mortality
Infection

Keywords

  • Clinical research/practice
  • Infection and infectious agents
  • Infectious disease
  • Kidney transplantation/nephrology
  • Organ acceptance
  • Patient survival
  • Scientific Registry for Transplant Recipients (SRTR)

ASJC Scopus subject areas

  • Immunology and Allergy
  • Transplantation
  • Pharmacology (medical)

Cite this

Turn down for what? Patient outcomes associated with declining increased infectious risk kidneys. / Bowring, Mary G.; Holscher, Courtenay M.; Zhou, Sheng; Massie, Allan B; Garonzik, Jacqueline; Kucirka, Lauren M.; Gentry, Sommer Elizabeth; Segev, Dorry.

In: American Journal of Transplantation, 01.01.2017.

Research output: Contribution to journalArticle

@article{af9512953daf48a5ba789b36cbd10cc1,
title = "Turn down for what? Patient outcomes associated with declining increased infectious risk kidneys",
abstract = "Transplant candidates who accept a kidney labeled increased risk for disease transmission (IRD) accept a low risk of window period infection, yet those who decline must wait for another offer that might harbor other risks or never even come. To characterize survival benefit of accepting IRD kidneys, we used 2010-2014 Scientific Registry of Transplant Recipients data to identify 104 998 adult transplant candidates who were offered IRD kidneys that were eventually accepted by someone; the median (interquartile range) Kidney Donor Profile Index (KDPI) of these kidneys was 30 (16-49). We followed patients from the offer decision until death or end-of-study. After 5 years, only 31.0{\%} of candidates who declined IRDs later received non-IRD deceased donor kidney transplants; the median KDPI of these non-IRD kidneys was 52, compared to 21 of the IRDs they had declined. After a brief risk period in the first 30 days following IRD acceptance (adjusted hazard ratio [aHR] accept vs decline: 1.222.063.49, P = .008) (absolute mortality 0.8{\%} vs. 0.4{\%}), those who accepted IRDs were at 33{\%} lower risk of death 1-6 months postdecision (aHR 0.500.670.90, P = .006), and at 48{\%} lower risk of death beyond 6 months postdecision (aHR 0.460.520.58, P < .001). Accepting an IRD kidney was associated with substantial long-term survival benefit; providers should consider this benefit when counseling patients on IRD offer acceptance.",
keywords = "Clinical research/practice, Infection and infectious agents, Infectious disease, Kidney transplantation/nephrology, Organ acceptance, Patient survival, Scientific Registry for Transplant Recipients (SRTR)",
author = "Bowring, {Mary G.} and Holscher, {Courtenay M.} and Sheng Zhou and Massie, {Allan B} and Jacqueline Garonzik and Kucirka, {Lauren M.} and Gentry, {Sommer Elizabeth} and Dorry Segev",
year = "2017",
month = "1",
day = "1",
doi = "10.1111/ajt.14577",
language = "English (US)",
journal = "American Journal of Transplantation",
issn = "1600-6135",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Turn down for what? Patient outcomes associated with declining increased infectious risk kidneys

AU - Bowring, Mary G.

AU - Holscher, Courtenay M.

AU - Zhou, Sheng

AU - Massie, Allan B

AU - Garonzik, Jacqueline

AU - Kucirka, Lauren M.

AU - Gentry, Sommer Elizabeth

AU - Segev, Dorry

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Transplant candidates who accept a kidney labeled increased risk for disease transmission (IRD) accept a low risk of window period infection, yet those who decline must wait for another offer that might harbor other risks or never even come. To characterize survival benefit of accepting IRD kidneys, we used 2010-2014 Scientific Registry of Transplant Recipients data to identify 104 998 adult transplant candidates who were offered IRD kidneys that were eventually accepted by someone; the median (interquartile range) Kidney Donor Profile Index (KDPI) of these kidneys was 30 (16-49). We followed patients from the offer decision until death or end-of-study. After 5 years, only 31.0% of candidates who declined IRDs later received non-IRD deceased donor kidney transplants; the median KDPI of these non-IRD kidneys was 52, compared to 21 of the IRDs they had declined. After a brief risk period in the first 30 days following IRD acceptance (adjusted hazard ratio [aHR] accept vs decline: 1.222.063.49, P = .008) (absolute mortality 0.8% vs. 0.4%), those who accepted IRDs were at 33% lower risk of death 1-6 months postdecision (aHR 0.500.670.90, P = .006), and at 48% lower risk of death beyond 6 months postdecision (aHR 0.460.520.58, P < .001). Accepting an IRD kidney was associated with substantial long-term survival benefit; providers should consider this benefit when counseling patients on IRD offer acceptance.

AB - Transplant candidates who accept a kidney labeled increased risk for disease transmission (IRD) accept a low risk of window period infection, yet those who decline must wait for another offer that might harbor other risks or never even come. To characterize survival benefit of accepting IRD kidneys, we used 2010-2014 Scientific Registry of Transplant Recipients data to identify 104 998 adult transplant candidates who were offered IRD kidneys that were eventually accepted by someone; the median (interquartile range) Kidney Donor Profile Index (KDPI) of these kidneys was 30 (16-49). We followed patients from the offer decision until death or end-of-study. After 5 years, only 31.0% of candidates who declined IRDs later received non-IRD deceased donor kidney transplants; the median KDPI of these non-IRD kidneys was 52, compared to 21 of the IRDs they had declined. After a brief risk period in the first 30 days following IRD acceptance (adjusted hazard ratio [aHR] accept vs decline: 1.222.063.49, P = .008) (absolute mortality 0.8% vs. 0.4%), those who accepted IRDs were at 33% lower risk of death 1-6 months postdecision (aHR 0.500.670.90, P = .006), and at 48% lower risk of death beyond 6 months postdecision (aHR 0.460.520.58, P < .001). Accepting an IRD kidney was associated with substantial long-term survival benefit; providers should consider this benefit when counseling patients on IRD offer acceptance.

KW - Clinical research/practice

KW - Infection and infectious agents

KW - Infectious disease

KW - Kidney transplantation/nephrology

KW - Organ acceptance

KW - Patient survival

KW - Scientific Registry for Transplant Recipients (SRTR)

UR - http://www.scopus.com/inward/record.url?scp=85037342447&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85037342447&partnerID=8YFLogxK

U2 - 10.1111/ajt.14577

DO - 10.1111/ajt.14577

M3 - Article

C2 - 29116674

AN - SCOPUS:85037342447

JO - American Journal of Transplantation

JF - American Journal of Transplantation

SN - 1600-6135

ER -